SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
INNATE IMMUNE DEFENSES AGAINST HIV-1 AND SARS-CoV-2
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
|
pages:
1
|
presentations:
1 to
4 of
4
|
FROM GENOME TO FUNCTION: PHENOTYPIC CHARACTERISATION OF PANDEMIC SARS-COV-2 VARIANTS
(ABSTRACT
23)
Volker Thiel
University of Bern, Bern, Switzerland
IMMUNE EVASION STRATEGIES BY SARS-COV-2: NSP1 AND BEYOND
(ABSTRACT
24)
Konstantin Sparrer
Ulm University, Ulm, Germany
SHARED VULNERABILITIES AND DIFFERENT COUNTERMEASURES OF HIV AND SARS-COV-2
(ABSTRACT
25)
Eric O Freed
National Cancer Institute, Frederick, MD, USA
IMMUNE RESPONSES TO SARS-COV-2
(ABSTRACT
26)
Akiko Iwasaki
Yale University, New Haven, CT, USA
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
|
pages:
1
|
presentations:
1 to
4 of
4
|
